A prospective study on comorbidities associated with Asthma and its Therapeutic outcomes
DOI:
https://doi.org/10.30904/j.ijrpls.2026.4962Keywords:
Asthma, Hyperresponsiveness, Corticosteroids, Generic drugs, Treatment guidelinesAbstract
Introduction: It is characterized by inflammation of the airways, causing intermittent airflow obstruction and bronchial hyperresponsiveness. Aim: The study aimed to assess risk burden of asthma associated comorbidities and its therapeutic outcomes in a tertiary care hospital. Methods: The prospective observational study was carried out for a period of 6 months. The study was conducted in General medicine department in a tertiary care hospital. A written and informed consent was obtained from the recruited patients. A Total of 200 patients were enrolled in the study. Results and Discussion: In our study 36-45 years age patients were more 67(33.5%) compared to other ages. In our study Male patients were more 142 (71%), compared to Female patients were 58 (29%). Risk factors profile for Asthma includes Viral infections patients were more 54 (27%) compared to other categories. Family history of Asthma includes positive patients were more 178(89%), compared to Negative patients were 22(11%). Severity of Asthma includes Mild Persistent patients were more 65(32.5%) compared to other categories. Co morbidities associated with Asthma includes Epilepsy patients were more 55 (27.5%) compared to other categories. The Treatment for Asthma includes corticosteroids prescribed patients were 54(27%) compared to other drugs. Conclusion: The study concludes that Health care professionals need to update with the current treatment guidelines. Prescribing of generic drugs should be promoted which would lower the economic burden and improve the patient compliance.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Author

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.